Records containing: Vascular Ehlers-Danlos Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-08Metabolic Phenotyping in Individuals With Vascular Ehlers-Danlos Syndrome (vEDS)
-
CLINICAL_TRIALS study record update · 2026-02-13Pathogenetic Basis of Aortopathy and Aortic Valve Disease
-
CLINICAL_TRIALS study record update · 2025-08-24A Phase 3 Randomized, Double-Blind, Decentralized Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in the Treatment of Patients With COL3A1-Positive Vascular Ehlers-Danlos Syndrome
-
CLINICAL_TRIALS study record update · 2024-10-26Virtual Single-Session "Empowered Relief" Class for Individuals with Marfan Syndrome and Related Conditions
-
CLINICAL_TRIALS study record update · 2024-07-01The Effects Of Heart Coherence Training On Patients With Vascular Ehlers-Danlos Syndrome (HEARTMATH)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-08A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome (vEDS) Confirmed With COL3A1 Mutations, Followed by an Open Label Extension (OLE)
-
CLINICAL_TRIALS study record update · 2023-05-09Disordered Bleeding in Ehlers Danlos Syndromes
-
CLINICAL_TRIALS study record update · 2016-03-17Identification of Plasmatic Biomarkers in Vascular Ehlers-Danlos Syndrome